Research location
Šahy
Slovakia
Advertisement
Research activity in Šahy
SlovakiaCureCurrent currently publishes aggregate city-level research activity for this location: 26 trials and 27 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Šahy
26 linked trials · page 1 of 1A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFNCT07761117 · 2026-08-24 · 1 site observation
RECRUITING
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose WeightNCT07533175 · 2026-04-13 · 1 site observation
RECRUITING
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%NCT04435626 · 2020-09-14 · 1 site observation
COMPLETED
A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.NCT03751657 · 2018-11-29 · 1 site observation
COMPLETED
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)NCT03071692 · 2017-03-23 · 1 site observation
TERMINATED
Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)NCT02227875 · 2014-08-01 · 1 site observation
COMPLETED
A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and ExerciseNCT01809327 · 2013-06-04 · 1 site observation
COMPLETED
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFRNCT01756716 · 2012-12-01 · 1 site observation
COMPLETED
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With AlbuminuriaNCT01756703 · 2012-11-01 · 1 site observation
COMPLETED
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseNCT01609582 · 2012-06-01 · 1 site observation
TERMINATED
Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 DiabetesNCT01549964 · 2012-04-01 · 1 site observation
TERMINATED
An Efficacy, Safety, and Tolerability Study of Canagliflozin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin MonotherapyNCT01340664 · 2011-07-01 · 1 site observation
COMPLETED
The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)NCT01106677 · 2010-05-01 · 1 site observation
COMPLETED
Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesNCT01023581 · 2009-11-01 · 1 site observation
COMPLETED
Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical PracticeNCT01061567 · 2009-11-01 · 1 site observation
COMPLETED
Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in HypertensionNCT00902538 · 2009-04-01 · 1 site observation
COMPLETED
Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 DiabetesNCT00821977 · 2008-11-01 · 1 site observation
COMPLETED
Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes MellitusNCT01079195 · 2007-10-01 · 2 site observations
COMPLETED
Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and PlaceboNCT00434967 · 2007-01-01 · 1 site observation
COMPLETED
Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes MellitusNCT00395512 · 2006-11-01 · 1 site observation
COMPLETED
G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)NCT00255645 · 2005-09-01 · 1 site observation
TERMINATED
GALLANT 22 Tesaglitazar vs. PlaceboNCT00252837 · 2005-04-01 · 1 site observation
TERMINATED
GALLEX 1 - Long Term Extension Study in Patients With Type 2 DiabetesNCT00252876 · 2005-03-01 · 1 site observation
TERMINATED
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesNCT00154401 · 2005-01-01 · 1 site observation
COMPLETED
Olmesartan Medoxomil and Diabetic NephropathyNCT00362960 · 2003-05-01 · 1 site observation
COMPLETED
RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in DiabetesNCT00379769 · 2001-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.